Clifford Swan Investment Counsel’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Sell
1,182
-5
-0.4% -$1.04K 0.01% 297
2026
Q1
$251K Sell
1,187
-41
-3% -$8.83K 0.01% 296
2025
Q4
$252K Buy
+1,228
New +$231K 0.01% 291
2025
Q3
Sell
-1,225
Closed -$206K 324
2025
Q2
$206K Buy
+1,225
New +$182K 0.01% 307
2024
Q4
Sell
-2,004
Closed -$221K 307
2024
Q3
$221K Buy
+2,004
New +$210K 0.01% 303
2016
Q1
Sell
-2,299
Closed -$205K 271
2015
Q4
$205K Buy
+2,299
New +$195K 0.01% 255

Other funds holding CAH

Clifford Swan Investment Counsel's CAH Position: Q2 2026 in Review

Clifford Swan Investment Counsel reduced its Cardinal Health (CAH) stake by 0.42% in Q2 2026, selling an estimated $1.04K and leaving 1,182 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #297.

Clifford Swan Investment Counsel first reported a position in CAH in Q4 2015 and has held it in 6 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Clifford Swan Investment Counsel held 1,182 shares of Cardinal Health worth $281K as of Q2 2026.
  • Clifford Swan Investment Counsel sold 5 Cardinal Health shares in Q2 2026, an estimated $1.04K.
  • Cardinal Health made up 0.01% of Clifford Swan Investment Counsel's portfolio in Q2 2026, its #297 holding.
  • Clifford Swan Investment Counsel first reported a position in Cardinal Health in Q4 2015 and has held it in 6 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2026, filed 20 Aug 2026.